CDH1 and lobular breast carcinoma in situ: Additionally, somatic CDH1 mutations are present in approximately 50% of sporadic cases of DGC [7], and loss of E-cadherin is a hallmark of lobular carcinoma in situ (LCIS) and LBC [8].